To get better insight into the management of non-metastatic castration-resistant prostate cancer (M0 CRPC), in this meta-analysis and review we aimed to present an updated evaluation of the efficacy and safety of novel hormonal therapies (nHT) for M0 CRPC according to final analyses with mature overall survival (OS) and safety data.
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data / Maggi, Martina; Salciccia, Stefano; Del Giudice, Francesco; Busetto, Gian Maria; Falagario, Ugo G; Carrieri, Giuseppe; Ferro, Matteo; Porreca, Angelo; Di Pierro, Giovanni Battista; Fasulo, Vittorio; Frantellizzi, Viviana; De Vincentis, Giuseppe; De Berardinis, Ettore; Sciarra, Alessandro. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 11:(2021). [10.3389/fonc.2021.700258]
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data
Maggi, MartinaPrimo
;Salciccia, StefanoSecondo
;Del Giudice, Francesco;Busetto, Gian Maria
;Di Pierro, Giovanni Battista;Frantellizzi, Viviana;De Vincentis, Giuseppe;De Berardinis, EttorePenultimo
;Sciarra, AlessandroUltimo
2021
Abstract
To get better insight into the management of non-metastatic castration-resistant prostate cancer (M0 CRPC), in this meta-analysis and review we aimed to present an updated evaluation of the efficacy and safety of novel hormonal therapies (nHT) for M0 CRPC according to final analyses with mature overall survival (OS) and safety data.| File | Dimensione | Formato | |
|---|---|---|---|
|
Maggi_Systematic-review_2021.pdf
accesso aperto
Note: https://www.frontiersin.org/articles/10.3389/fonc.2021.700258/full
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.39 MB
Formato
Adobe PDF
|
2.39 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
